DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Ponticelli C, Yussim A, Cambi V, Legendre C, Rizzo G, Salvadori M, Kahn D, Kashi H, Salmela K, Fricke L, Heemann U, Garcia-Martinez J, Lechler R, Prestele H, Girault D. Simulect Phase IV Study Group.
A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.
Transplantation 2001; 72: 1261-1267
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.